Cantitate/Preț
Produs

Mechanisms and Therapy of Liver Cancer: Advances in Cancer Research, cartea 149

Paul B. Fisher, Devanand Sarkar
en Limba Engleză Hardback – 10 feb 2021
Mechanisms and Therapy of Liver Cancer, Volume 149, presents the latest information on the incidence and mortality of liver cancer research and how it has gained significant momentum because of its direct causative association with obesity-induced fatty liver disease. The literature on liver cancer is moving fast with exciting, novel findings, providing new insights reflected in the following updated chapters: Introduction and molecular classification of HCC, Signaling Pathways in Liver Cancer, HCV and HCC, NASH and HCC, Microbiome and Metabolic Abnormalities in HCC, Systemic Therapy of Liver Cancer, Immunotherapy of Liver Cancer, and Desmoplastic Tumor Microenvironment and Intrahepatic Cholangiocarcinoma Progression: Mechanisms and Therapeutic Implications.

  • Provides the latest information on liver cancer research
  • Offers outstanding and original reviews on a range of topics focused on liver cancer
  • Serves as an indispensable reference on liver cancer for researchers and students alike
Citește tot Restrânge

Din seria Advances in Cancer Research

Preț: 72141 lei

Preț vechi: 96552 lei
-25% Nou

Puncte Express: 1082

Preț estimativ în valută:
13811 15054$ 11613£

Carte tipărită la comandă

Livrare economică 11-25 decembrie

Preluare comenzi: 021 569.72.76

Specificații

ISBN-13: 9780128240304
ISBN-10: 012824030X
Pagini: 402
Dimensiuni: 152 x 229 mm
Greutate: 0.7 kg
Editura: ELSEVIER SCIENCE
Seria Advances in Cancer Research


Public țintă

Researchers and students in basic and translational cancer research, with special emphasis on liver diseases and liver cancer, as well as related areas in genetics, immunology, pharmacology and cell and molecular biology

Cuprins

1. Hepatocellular carcinoma (HCC): Epidemiology, etiology and molecular classification
Saranya Chidambaranathan-Reghupaty, Paul B. Fisher, and Devanand Sarkar
2. Signaling pathways in hepatocellular carcinoma
Teresa Garcia-Lezana, Juan Luis Lopez-Canovas, and Augusto Villanueva
3. Hepatitis C virus associated hepatocellular carcinoma
Mousumi Khatun, Ranjit Ray, and Ratna B. Ray
4. NAFLD-related HCC
Bubu A. Banini and Arun J. Sanyal
5. Atypical immunometabolism and metabolic reprogramming in liver cancer: Deciphering the role of gut microbiome
Rachel M. Golonka and Matam Vijay-Kumar
6. Systemic therapy of liver cancer
Tarik Demir, Sunyoung S. Lee, and Ahmed O. Kaseb
7. Immunotherapy in hepatocellular cancer
Christos Fountzilas, Rachel Evans, Sabah Alaklabi, and Renuka Iyer
8. Intrahepatic cholangiocarcinoma: Morpho-molecular pathology, tumor reactive microenvironment, and malignant progression
Alphonse E. Sirica, Mario Strazzabosco, and Massimiliano Cadamuro

Recenzii

"Provides the latest information on liver cancer research; Offers outstanding and original reviews on a range of topics focused on liver cancer; Serves as an indispensable reference on liver cancer for researchers and students alike." --Anticancer Research